J&J Appeals Invalidity Ruling For Stent Patents

Law360, New York (February 18, 2010, 1:11 PM EST) -- Johnson & Johnson Inc. has appealed a federal court's ruling in favor of plaintiff Boston Scientific Corp. that four of J&J's patents for drug-eluting stents are invalid.

According to the notice of appeal, filed Wednesday in the U.S. District Court for the District of Delaware, J&J will ask the U.S. Court of Appeals for the Federal Circuit to reverse the district court's orders construing J&J's patents and granting BSC summary judgment of invalidity.

Attorneys for the parties could not immediately be reached for comment on Thursday....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.